SitesBLAST
Comparing WP_110753777.1 NCBI__GCF_003217235.1:WP_110753777.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
Q70DU8 Aldehyde dehydrogenase family 3 member H1; AtALDH4; Ath-ALDH4; EC 1.2.1.3 from Arabidopsis thaliana (Mouse-ear cress) (see 2 papers)
35% identity, 97% coverage: 1:446/458 of query aligns to 15:459/484 of Q70DU8
- C45 (≠ L31) mutation to S: Decreased solubility, loss of dimerization and strongly decreased activity.
- E149 (= E136) mutation to D: Small effect on NAD(+) interaction, but 40% loss of efficiency. Ability to use NADP(+). 70% loss of efficiency with NAD(+); when associated with V-200. Impaired affinity for both cofactors and decreased catalytic efficiency; when associated with G-200.; mutation to N: Ability to use NADP(+) and 33% decreased efficiency with NAD(+). 70% loss of efficiency with NAD(+); when associated with V-200. Impaired affinity for both cofactors and decreased catalytic efficiency; when associated with G-200.; mutation to Q: Loss of specificity for NAD(+) and loss of 25% efficiency. 15% efficiency with NAD(+); when associated with V-200. Impaired affinity for both cofactors and decreased catalytic efficiency; when associated with G-200.; mutation to T: Loss of specificity and increased NADP(+) binding. Decreased catalytic efficiency. Loss of cofactor specificity and same lower efficiency with both; when associated with V-200. Impaired affinity for both cofactors and decreased catalytic efficiency; when associated with G-200. Changed coenzyme preference from NAD(+) to NADP(+), but no effect on the catalytic efficiency; when associated with R-178 and V-200.
- V178 (= V165) mutation to R: Changed coenzyme preference from NAD(+) to NADP(+), but no effect on the catalytic efficiency; when associated with T-149 and V-200.
- I200 (≠ V187) mutation to G: Changed coenzyme preference from NAD(+) to NADP(+), but impaired affinities for both cofactors. No effect on the interaction with the substrate. Impaired affinities for both cofactors and decreased catalytic efficiencies; when associated with D-149, Q-149, N-149 or T-149.; mutation to V: Also able to use NADP(+) as coenzyme, but no effect on the interaction with the substrate. 15% efficiency with NAD(+); when associated with Q-149. 70% loss of efficiency with NAD(+); when associated with D-149 or N-149. Loss of cofactor specificity and same lower efficiency with both; when associated with T-149. Changed coenzyme preference from NAD(+) to NADP(+), but no effect on the catalytic efficiency; when associated with T-149 and R-178.
- C247 (≠ M233) mutation to S: No effect on solubility, but 10% loss of activity.
- C253 (= C239) mutation to S: No effect on solubility, but loss of activity.
1ad3A Class 3 aldehyde dehydrogenase complex with nicotinamide-adenine- dinucleotide (see paper)
36% identity, 95% coverage: 2:435/458 of query aligns to 6:433/446 of 1ad3A
- active site: N113 (= N110), K136 (= K133), E208 (= E205), C242 (= C239), E332 (= E334), Y411 (= Y413)
- binding nicotinamide-adenine-dinucleotide: A111 (≠ P108), W112 (= W109), N113 (= N110), E139 (= E136), V140 (≠ L137), V168 (= V165), G186 (= G183), V190 (= V187), H288 (= H285), R291 (≠ L288), E332 (= E334), F334 (= F336)
P51648 Aldehyde dehydrogenase family 3 member A2; Aldehyde dehydrogenase 10; Fatty aldehyde dehydrogenase; Microsomal aldehyde dehydrogenase; EC 1.2.1.3; EC 1.2.1.94 from Homo sapiens (Human) (see 5 papers)
37% identity, 93% coverage: 2:426/458 of query aligns to 5:423/485 of P51648
- I45 (≠ V42) to F: in SLS; severe loss of activity
- V64 (≠ L62) to D: in SLS; severe loss of activity; dbSNP:rs72547556
- L106 (≠ G104) to R: in SLS; severe loss of activity; dbSNP:rs72547558
- N112 (= N110) mutation to A: Loss of enzyme activity.
- P114 (= P112) to L: in SLS; severe loss of activity; dbSNP:rs72547559
- P121 (= P119) to L: in SLS; severe loss of activity; dbSNP:rs72547560
- T184 (= T182) to M: in SLS; severe loss of activity; dbSNP:rs72547562; to R: in SLS; severe loss of activity
- G185 (= G183) to A: in SLS; severe loss of activity; dbSNP:rs72547563
- E207 (= E205) active site; mutation to Q: Loss of enzyme activity.
- C214 (≠ A212) to Y: in SLS; 4% of activity; dbSNP:rs72547564
- R228 (≠ D226) to C: in SLS; severe loss of activity; dbSNP:rs72547566
- C237 (≠ A235) to Y: in SLS; severe loss of activity; dbSNP:rs72547567
- C241 (= C239) active site; mutation to S: Loss of enzyme activity.
- D245 (= D243) to N: in SLS; severe loss of activity; dbSNP:rs72547568
- K266 (≠ E264) to N: in SLS; mild reduction of activity; the underlying nucleotide substitution affects transcript stability; dbSNP:rs72547569
- Y279 (= Y276) to N: in SLS; severe loss of activity; dbSNP:rs72547570
- AP 314:315 (≠ PP 317:318) natural variant: AP -> GAKSTVGA (in SLS; 8% of activity)
- P315 (= P318) to S: in SLS; common mutation in Europeans; severe loss of enzymatic activity; dbSNP:rs72547571
- E331 (= E334) mutation to Q: Loss of enzyme activity.
- S365 (≠ T368) to L: in SLS; severe loss of activity; dbSNP:rs72547573
- Y410 (= Y413) mutation to F: Decreased enzyme activity with dodecanal and hexadecanal. No effect on enzyme activity with octanal.
- H411 (= H414) to Y: in SLS; severe loss of activity
- S415 (≠ G418) to N: in SLS; severe loss of activity
- F419 (= F422) to S: in SLS; severe loss of activity; dbSNP:rs72547576
- R423 (= R426) to H: in SLS; severe loss of activity; dbSNP:rs768290318
Sites not aligning to the query:
- 445:485 mutation Missing: Decreased enzyme activity with dodecanal. Strongly decreased enzyme activity with hexadecanal. No effect on enzyme activity with octanal.
- 447 K → E: in SLS; severe loss of activity; dbSNP:rs67939114
Q8W033 Aldehyde dehydrogenase family 3 member I1, chloroplastic; AtALDH3; Ath-ALDH3; EC 1.2.1.3 from Arabidopsis thaliana (Mouse-ear cress) (see paper)
36% identity, 97% coverage: 1:444/458 of query aligns to 78:520/550 of Q8W033
- C114 (≠ A37) mutation to S: No effect on solubility, but loss of dimerization and 80% loss of activity.
- C142 (≠ L66) mutation to S: No effect on solubility, but decreased activity.
- V263 (= V187) mutation to I: No effect on substrate specificity, but decreased affinity for NADP(+) and increased affinity for NAD(+).
- C286 (≠ S210) mutation to S: No effect on solubility, but no effect on activity.
- C310 (≠ M233) mutation to S: No effect on solubility, but no effect on activity.
- C316 (= C239) mutation to S: No effect on solubility, but loss of activity.
P30838 Aldehyde dehydrogenase, dimeric NADP-preferring; ALDHIII; Aldehyde dehydrogenase 3; Aldehyde dehydrogenase family 3 member A1; EC 1.2.1.5 from Homo sapiens (Human) (see 4 papers)
35% identity, 93% coverage: 2:426/458 of query aligns to 8:426/453 of P30838
- S134 (≠ R129) to A: in dbSNP:rs887241
- E210 (= E205) active site
- C244 (= C239) active site; mutation to S: Abolishes activity.
- P329 (≠ L329) to A: in allele ALDH3A1*2; dbSNP:rs2228100
8bb8A Crystal structure of human aldehyde dehydrogenase aldh3a1 in complex with octanal (see paper)
36% identity, 93% coverage: 2:426/458 of query aligns to 7:425/447 of 8bb8A
4l1oB Crystal structure of human aldh3a1 with inhibitor 1-{[4-(1,3- benzodioxol-5-ylmethyl)piperazin-1-yl]methyl}-1h-indole-2,3-dione (see paper)
36% identity, 93% coverage: 2:426/458 of query aligns to 7:425/452 of 4l1oB
- active site: N114 (= N110), K137 (= K133), E209 (= E205), C243 (= C239), E333 (= E334), Y412 (= Y413)
- binding (3S)-1-{[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl}-3-hydroxy-1,3-dihydro-2H-indol-2-one: Y115 (= Y111), N118 (≠ L114), L119 (= L115), E209 (= E205), T242 (= T238), C243 (= C239), I391 (≠ L392), I394 (= I395), F401 (= F402), H413 (= H414)
4l2oA Crystal structure of human aldh3a1 with its selective inhibitor 1-(4- fluorophenyl)sulfonyl-2-methylbenzimidazole
35% identity, 93% coverage: 2:426/458 of query aligns to 7:425/446 of 4l2oA
- active site: N114 (= N110), K137 (= K133), E209 (= E205), C243 (= C239), E333 (= E334), Y412 (= Y413)
- binding 1-[(4-fluorophenyl)sulfonyl]-2-methyl-1H-benzimidazole: E61 (≠ L57), Y65 (≠ P61), Y115 (= Y111), N118 (≠ L114), L119 (= L115), M237 (= M233), C243 (= C239), I391 (≠ L392), I394 (= I395), T395 (≠ A396), F401 (= F402), H413 (= H414)
- binding nicotinamide-adenine-dinucleotide: T112 (≠ P108), W113 (= W109), N114 (= N110), L119 (= L115), E140 (= E136), V169 (= V165), T186 (= T182), G187 (= G183), S188 (= S184), V191 (= V187), E209 (= E205), L210 (= L206), G211 (= G207), C243 (= C239), H289 (≠ A284), E333 (= E334), F335 (= F336), F401 (= F402)
4h80A Crystal structure of human aldh3a1 with its isozyme selective inhibitor - n-[4-(4-methylsulfonyl-2-nitroanilino)phenyl]acetamide
35% identity, 93% coverage: 2:426/458 of query aligns to 7:425/446 of 4h80A
- active site: N114 (= N110), K137 (= K133), E209 (= E205), C243 (= C239), E333 (= E334), Y412 (= Y413)
- binding N-(4-{[4-(methylsulfonyl)-2-nitrophenyl]amino}phenyl)acetamide: E61 (≠ L57), Y65 (≠ P61), Y115 (= Y111), N118 (≠ L114), W233 (≠ F229), T242 (= T238), C243 (= C239), V244 (≠ I240), I394 (= I395), T395 (≠ A396), F401 (= F402)
3szbA Crystal structure of human aldh3a1 modified with the beta-elimination product of aldi-1; 1-phenyl- 2-propen-1-one (see paper)
35% identity, 93% coverage: 2:426/458 of query aligns to 7:425/447 of 3szbA
P43353 Aldehyde dehydrogenase family 3 member B1; Aldehyde dehydrogenase 7; EC 1.2.1.28; EC 1.2.1.5; EC 1.2.1.7 from Homo sapiens (Human) (see paper)
37% identity, 93% coverage: 2:426/458 of query aligns to 8:426/468 of P43353